Navigation Links
Phlo Affiliate to Launch AQUISS(TM) on East Coast

Greater Metropolitan NYC and Long Island

JACKSONVILLE, Fla., Oct. 11 /PRNewswire-FirstCall/ -- An affiliate of Phlo Corporation (OTC: PHLC) (the "Company") announced today that it will launch its vitality beverage product, AQUISS(TM), on the East Coast in November.

AQUISS(TM) initially will be distributed in the greater metropolitan New York City area, including Manhattan, Brooklyn, Queens, the Bronx, and Long Island. Aquiss(TM) will be launched in all channels of distribution, including chain grocers, chain convenience stores, chain drug stores, independent grocers, independent convenience stores, and mass merchandisers.

"Our East Coast launch will provide us with tremendous coverage in one of the most populated and valuable pieces of the world -- the impact on corporate value should be significant, as coverage in this region provides in most every field," said James B. Hovis, CEO of the Company.

AQUISS(TM) features the Company's Instant Nano Hydration and Cell Armor technologies, providing instant, direct delivery of rehydration and cell- repair-and-protection payloads into the bloodstream beginning through the membranes of the mouth. These Instant Nano Hydration and Cell Armor technologies help provide sustained wellness necessary for life's performances and vigorous longevity. In addition, the Company's nano-encapsulation technology prevents the destruction of its active payloads in the stomach.

Phlo is a biotechnology company and a manufacturer and marketer of products (primarily liquids) containing patented and patent-pending biotechnologies. Phlo is focusing its technology generation and acquisition efforts on those technologies related to enhancing cognition and personal performance, reducing the effects of aging, and preventing or ameliorating cancer.

Certain statements made herein that are not historical constitute "forward-looking" statements within the meaning of the Private Litigation Reform Act of 1995 and may contain words such as "anticipate," "believe," "expect," "future," "may," "will," "should," "plan," "projected," "intend," and similar expressions to identify such forward-looking statements. Such statements are based on a number of assumptions and on information and estimates supplied to Phlo Corporation by sources currently available to it. Such assumptions and estimates are subject to uncertainties, contingencies, and other factors, many of which are beyond Phlo Corporation's control. Actual results may differ materially from the statements set forth above.

SOURCE Phlo Corporation
Copyright©2007 PR Newswire.
All rights reserved

Related biology technology :

1. Bruker AXS parent buys affiliate company
2. Merge launches diagnostic mammography workstation in Europe
3. Einstein Wireless launches cellular alert system
4. Logistics Health launches compliance management tool
5. UW-Madison launches new high-speed research network
6. UWM launches research foundation
7. Weather information companies launch data product
8. TeraMedica launches information manager
9. GE Healthcare launches hybrid electronic record
10. Cedara launches new version of DICOM toolkit
11. Merge launches Spanish version of imaging tool
Post Your Comments:
(Date:6/24/2016)... June 24, 2016  Regular discussions on a range of ... between the two entities said Poloz. Speaking at ... Ottawa , he pointed to the country,s inflation target, ... government. "In certain ... institutions have common economic goals, why not sit down and ...
(Date:6/24/2016)... ... 24, 2016 , ... While the majority of commercial spectrophotometers and fluorometers use ... 6000i models are higher end machines that use the more unconventional z-dimension of 20mm. ... from the bottom of the cuvette holder. , FireflySci has developed several Agilent ...
(Date:6/23/2016)... ... June 23, 2016 , ... Mosio, ... second eBook, “Clinical Trials Patient Recruitment and Retention Tips.” Partnering with experienced clinical ... eBook by providing practical tips, tools, and strategies for clinical researchers. , “The ...
(Date:6/23/2016)... 2016   Boston Biomedical , an industry ... to target cancer stemness pathways, announced that its ... Drug Designation from the U.S. Food and Drug ... including gastroesophageal junction (GEJ) cancer. Napabucasin is an ... cancer stemness pathways by targeting STAT3, and is ...
Breaking Biology Technology:
(Date:6/22/2016)... June 22, 2016 On Monday, the Department ... industry to share solutions for the Biometric Exit Program. ... and Border Protection (CBP), explains that CBP intends to ... the United States , in order ... defeat imposters. Logo - ...
(Date:6/16/2016)... The global Biometric ... USD 1.83 billion by 2024, according to a ... proliferation and increasing demand in commercial buildings, consumer ... the market growth.      (Logo: ... of advanced multimodal techniques for biometric authentication and ...
(Date:6/9/2016)... TURKU, Finland , June 9, 2016 ... French National Police deploy Teleste,s video security solution to ensure ... France during the major tournament ... and data communications systems and services, announced today that its ... Police Prefecture to back up public safety across ...
Breaking Biology News(10 mins):